ArticleBreast cancer research and treatment2023

Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34.

Kristin A Altwegg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.